UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

A role for nebulized tranexamic acid in veno‐venous ECMO patients

Journal of clinical pharmacy and therapeutics, 2022-01, Vol.47 (1), p.125-128

2022

Volltextzugriff (PDF)

Short versus long duration of ceftaroline combination therapy and outcomes in persistent or high-grade MRSA bacteremia: A retrospective single-center study

PloS one, 2024-05, Vol.19 (5), p.e0304103-e0304103

2024

Volltextzugriff (PDF)

Development of a leadership certificate program for postgraduate year 1 pharmacy residents at an academic medical center

American journal of health-system pharmacy, 2018-10, Vol.75 (19), p.1446-1447

2018

Volltextzugriff (PDF)

The influence of continuous renal replacement therapy on 1,3-β- d -glucan levels in critically ill patients: a single-center retrospective propensity score study

Renal failure, 2023, Vol.45 (2), p.2255680-2255680

2023

Volltextzugriff (PDF)

Breaking the mold: Insights into the clinical management and outcomes of rhinocerebral mucormycosis in adults

IDCases, 2024-01, Vol.37, p.e02024, Article e02024

2024

Volltextzugriff (PDF)

A successful daptomycin and micafungin dosing strategy in veno‐venous ECMO and continuous renal replacement

Journal of clinical pharmacy and therapeutics, 2022-02, Vol.47 (2), p.251-253

2022

Volltextzugriff (PDF)

A case series of Corynebacterium striatum native valve infective endocarditis

Journal of cardiology cases, 2022-09, Vol.26 (3), p.194-196

2022

Volltextzugriff (PDF)

A Retrospective Cohort Study Comparing Dual Therapy With Ceftaroline With Vancomycin or Daptomycin Monotherapy for High-Grade or Persistent MRSA Bacteremia

The Journal of pharmacy technology, 2024-06, Vol.40 (3), p.134-141

2024

Volltextzugriff (PDF)

ONE FOR THE MONEY, TWO FOR THE ECMO: A SUCCESSFUL PHARMACOTHERAPEUTIC STRATEGY FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM AND CANDIDA GLABRATA FUNGEMIA IN VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION AND CONTINUOUS RENAL REPLACEMENT

Chest, 2020-10, Vol.158 (4), p.A716-A716

2020

Volltextzugriff (PDF)

174. Impact of Ceftaroline Duration after Bacteremia Clearance When Used in Combination Therapy for Persistent or High-grade MRSA Bacteremia

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

925. Adverse Events Due to Inappropriate Prescribing in Older Adults Living with HIV

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S496-S496

2020

Volltextzugriff (PDF)

2779. Early Administration of Ceftazidime-Avibactam for Carbapenem-Resistant Enterobacterales Is Associated with Improved Clinical Success

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

1082. Real-World Experience with Omadacycline for Nontuberculous Mycobacterial Infections: A Multicenter Evaluation

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S632-S633

2021

Volltextzugriff (PDF)

A successful daptomycin and micafungin dosing strategy in veno-venous ECMO and continuous renal replacement

Journal of clinical pharmacy and therapeutics, 2022, Vol.47 (2), p.251-253

2022

Volltextzugriff (PDF)

A case series of Corynebacterium striatum native valve infective endocarditis

Journal of cardiology cases, 2022, Vol.26 (3), p.194-196

2022

Volltextzugriff (PDF)

A role for nebulized tranexamic acid in veno-venous ECMO patients

Journal of clinical pharmacy and therapeutics, 2022, Vol.47 (1), p.125-128

2022

Volltextzugriff (PDF)

Implementation and providers' views of a pharmacist clinician on an inpatient infectious diseases consult service at an academic medical center

JAACP : Journal of the American College of Clinical Pharmacy, 2021-10, Vol.4 (10), p.1274-1279

2021

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(15)
Berichte
(3)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(9)
Life Sciences & Biomedicine
(8)
Pharmacology & Pharmacy
(6)
Humans
(4)
Male
(4)
Aged
(3)
Bacteremia
(3)
Infectious Diseases
(3)
Antifungal Agents
(2)
Bacteremia - Drug Therapy
(2)
Case Report
(2)
Case Reports
(2)
Ceftaroline
(2)
Continuous Renal Replacement Therapy
(2)
Female
(2)
Middle Aged
(2)
Patients
(2)
Poster Abstracts
(2)
Retrospective Studies
(2)
Acids
(1)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A role for nebulized tranexamic acid in veno‐venous ECMO patients

Short versus long duration of ceftaroline combination therapy and outcomes in persistent or high-grade MRSA bacteremia: A retrospective single-center study

Development of a leadership certificate program for postgraduate year 1 pharmacy residents at an academic medical center

The influence of continuous renal replacement therapy on 1,3-β- d -glucan levels in critically ill patients: a single-center retrospective propensity score study

Breaking the mold: Insights into the clinical management and outcomes of rhinocerebral mucormycosis in adults

A successful daptomycin and micafungin dosing strategy in veno‐venous ECMO and continuous renal replacement

Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes

A case series of Corynebacterium striatum native valve infective endocarditis

A Retrospective Cohort Study Comparing Dual Therapy With Ceftaroline With Vancomycin or Daptomycin Monotherapy for High-Grade or Persistent MRSA Bacteremia

ONE FOR THE MONEY, TWO FOR THE ECMO: A SUCCESSFUL PHARMACOTHERAPEUTIC STRATEGY FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM AND CANDIDA GLABRATA FUNGEMIA IN VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION AND CONTINUOUS RENAL REPLACEMENT

174. Impact of Ceftaroline Duration after Bacteremia Clearance When Used in Combination Therapy for Persistent or High-grade MRSA Bacteremia

925. Adverse Events Due to Inappropriate Prescribing in Older Adults Living with HIV

2779. Early Administration of Ceftazidime-Avibactam for Carbapenem-Resistant Enterobacterales Is Associated with Improved Clinical Success

1082. Real-World Experience with Omadacycline for Nontuberculous Mycobacterial Infections: A Multicenter Evaluation

A successful daptomycin and micafungin dosing strategy in veno-venous ECMO and continuous renal replacement

A case series of Corynebacterium striatum native valve infective endocarditis

A role for nebulized tranexamic acid in veno-venous ECMO patients

Implementation and providers' views of a pharmacist clinician on an inpatient infectious diseases consult service at an academic medical center

Suchergebnisse filtern